Advances in Chronic Kidney Disease
Volume 12, Issue 4 , Pages 378-384 , October 2005

Hypertension in Children with Chronic Kidney Disease

  • Ibrahim F. Shatat

      Affiliations

    • Section of Pediatric Nephrology, Children’s Hospital at Montefiore, Montefiore Medical Center, Bronx, NY, USA
    • Department of Pediatrics, Albert Einstein College of Medicine, Bronx, NY, USA
    • ,
  • Joseph T. Flynn

      Affiliations

    • Section of Pediatric Nephrology, Children’s Hospital at Montefiore, Montefiore Medical Center, Bronx, NY, USA
    • Department of Pediatrics, Albert Einstein College of Medicine, Bronx, NY, USA
    • Corresponding Author InformationAddress correspondence to Joseph T. Flynn, MD, MS, Division of Pediatric Nephrology, Montefiore Medical Center, 111 East 210th Street, Bronx, NY 10467

References 

  1. Kidney Disease Outcomes Quality Initiative (K/DOQI) (K/DOQI clinical practice guidelines on hypertension and antihypertensive agents in chronic kidney disease) . Am J Kidney Dis . 2004;43(suppl 1):S1–S290
  2. Bakris GL , Williams M , Dworkin L , et al.   Preserving renal function in adults with hypertension and diabetes (A consensus approach) . Am J Kidney Dis . 2000;36:646–661
  3. National High Blood Pressure Education Program Working Group on High Blood Pressure in Children and Adolescents . The fourth report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents . Pediatrics . 2004;114:555–576
  4. Chobanian AV , Bakris GL , Black HR , et al.   The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (The JNC 7 report) . JAMA . 2003;289:2560–2572
  5. North American Pediatric Renal Transplant Cooperative Study . 2004 Annual Report . Potomac, MD: Emmes Corporation; 2005;
  6. Fivush BA , Jabs K , Neu AM , et al.   Chronic renal insufficiency in children and adolescents (The 1996 annual report of NAPRTCS) . Pediatr Nephrol . 1998;12:328–337
  7. Flynn JT , Smoyer WE , Bunchman TE . Treatment of hypertensive children with amlodipine . Am J Hypertens . 2000;13:1061–1066
  8. Wells T , Frame V , Soffer B , et al.   A double-blind, placebo-controlled, dose-response study of the effectiveness and safety of enalapril for children with hypertension . J Clin Pharmacol . 2002;42:870–880
  9. Sorof JM , Poffenbarger T , Portman R . Abnormal 24-hour blood pressure patterns in children after renal transplantation . Am J Kidney Dis . 2000;35:681–686
  10. Nagasako SS , Koch Nogueira PC , et al.   Arterial hypertension following renal transplantation in children—a short-term study . Pediatr Nephrol . 2003;18:1270–1274
  11. US Renal Data System: USRDS 2002 Annual Data Report: Atlas of End-Stage Renal Disease in the United States . Bethesda, MD: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases; 2002;
  12. Klag MJ , Whelton PK , Randall BL , et al.   Blood pressure and end-stage renal disease in men . N Engl J Med . 1996;334:13–18
  13. Peterson JC , Adler S , Burkart JM , et al.   Blood pressure control, proteinuria, and the progression of renal disease (The Modification of Diet in Renal Disease Study) . Ann Intern Med . 1995;123:754–762
  14. Mitsnefes M , Ho P-L , McEnery PT . Hypertension and progression of chronic renal insufficiency in children (A report of the North American Pediatric Renal Transplant Cooperative Study (NAPRTICS)) . J Am Soc Nephrol . 2003;14:2618–2622
  15. Wingen A-M , Fabian-Bach C , Schaefer F , et al.   Randomised multicentre study of a low-protein diet on the progression of chronic renal failure in children . Lancet . 1997;349:1117–1123
  16. Soergel M , Schaefer F . Effect of hypertension on the progression of chronic renal failure in children . Am J Hypertens . 2002;15(suppl):53S–56S
  17. Riser BL , Cortes P , Zhao X , et al.   Intraglomerular pressure and mesangial stretching stimulate extracellular matrix formationin the rat . J Clin Invest . 1992;90:1932–1943
  18. Johnsson E , Rippe B , Haraldsson B . Reduced permselectivity in isolated perfused rat kidneys following small elevations of glomerular capillary pressure . Acta Physiol Scand . 1994;150:201–209
  19. Lewington AJ , Arici M , Harris KP , et al.   Modulation of the rennin-angiotensin system in proteinuric renal disease (Are these added benefits?) . Nephrol Dial Transplant . 2001;16:885–888
  20. Zucchelli P , Zuccala A . Progression of renal failure and hypertensive nephrosclerosis . Kidney Int . 1998;68(suppl):S55–S59
  21. Weigert C , Brodbeck K , Brosius FC , et al.   Evidence for a novel TGF-β1-independent mechanism of fibronectin production in mesangial cells overexpressing glucose transporters . Diabetes . 2003;52:527–535
  22. McLaughlin KJ , Harden PN , Ueda S , et al.   The role of genetic polymorphisms of angiotensin-converting enzyme in the progression of renal diseases . Hypertension . 1996;28:912–915
  23. Ruggenenti P , Perna A , Gherardi G , et al.   Randomized placebo-controlled trial of effect of remipril on decline in glomerular filtration rate and risk of terminal renal failure in proteinuric, non-diabetic nephropathy (The GISEN Group (Gruppo Italiano di Studi Epidemiologici in Nefrologia)) . Lancet . 1998;352:1252–1256
  24. Maschio G , Alberti D , Janin G , et al.   Effect of the angiotensin-converting-enzyme inhibitor benazepril on the progression of chronic renal insufficiency . N Engl J Med . 1996;334:939–945
  25. Jafar TH , Schmid CH , Landa M , et al.   Angiotensin-converting enzyme inhibitors and progression of nondiabetic renal disease (A meta-analysis of patient-level data) . Ann Intern Med . 2001;135:73–87
  26. Giatras I , Lau J , Levey AS . Effect of angiotensin-converting enzyme inhibitors on the progression of nondiabetic renal disease (A meta-analysis of randomized trials) . Angiotensin-Converting-Enzyme Inhibition and Progressive Renal Disease Study Group. Ann Intern Med . 1997;127:337–345
  27. Kshirsagar AV , Joy MS , Hogan SL , Falk RJ , Colindres RE . Effect of ACE inhibitors in diabetic and nondiabetic chronic renal disease (A systematic overview of randomized placebo-controlled trials) . Am J Kidney Dis . 2000;35:695–707
  28. Gansevoort RT , de Zeeuw D , Shahinfar S , et al.   Effects of the angiotensin II antagonist losartan in hypertensive patients with renal disease . J Hypertens . 1994;12(suppl):S37–S42
  29. Lewis EJ , Hunsicker LG , Clarke WR , et al.   Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes . N Engl J Med . 2001;345:851–860
  30. Nakao N , Yoshimura A , Morita H , et al.   Combination treatment of angiotensin-II receptor blocker and angiotensin-converting-enzyme inhibitor in non-diabetic renal disease (COOPERATE) (A randomized controlled trial) . Lancet . 2003;361:117–124
  31. Seeman T , Dusek J , Vondrak K , et al.   Ramipril in the treatment of hypertension and proteinuria in children with chronic kidney diseases . Am J Hypertens . 2004;17:415–420
  32. Wühl E , Mehls O , Schaefer F . ESCAPE Trial Group (Antihypertensive and antiproteinuric efficacy of ramipril in children with chronic renal failure) . Kidney Int . 2004;66:768–776
  33. Ellis D , Vats A , Moritz ML , et al.   Long-term antiproteinuric and renoprotective efficacy and safety of losartan in children with proteinuria . J Pediatr . 2003;143:89–97
  34. Woroniecki RP , Flynn JT . How are hypertensive children evaluated and managed? . A survey of North American pediatric nephrologists. Pediatr Nephrol . 2005;20:791–797

PII: S1548-5595(05)00115-1

doi: 10.1053/j.ackd.2005.07.002

Advances in Chronic Kidney Disease
Volume 12, Issue 4 , Pages 378-384 , October 2005

Article Tools

* Image Usage & Resolution